Adagio Therapeutics GAAP EPS of -$0.47

Aug. 15, 2022 7:58 AM ETInvivyd, Inc. (IVVD)By: Deepa Sarvaiya, SA News Editor
  • Adagio Therapeutics press release (NASDAQ:ADGI): Q2 GAAP EPS of -$0.47.
  • Cash and cash equivalents were $475 million as of June 30, 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.